DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Toluene is an investigational drug.
There have been 9 clinical trials for Toluene. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2009.
The most common disease conditions in clinical trials are Carcinoma, Liver Neoplasms, and Lymphoma, T-Cell. The leading clinical trial sponsors are PTS International Inc., National Cancer Institute (NCI), and Gongwin Biopharm Co., Ltd.
Recent Clinical Trials for Toluene
|Treatment of Non-small Cell Lung Cancer With PD-1 Monoclonal Antibody Combined With Donafenib Toluene Sulfonate||First Affiliated Hospital of Zhejiang University||Phase 1|
|A Phase II Study of PTS100 in Primary HCC Patients||Gongwin Biopharm Co., Ltd.||Phase 2|
|A Study of PTS for Patients With Solid Tumors||PTS International Inc.||Phase 1|